You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Entrepreneurs: Astellas wants to help you launch your dream! With a strong commitment to supporting cutting-edge science that can bring VALUE to patients, Astellas is proud to sponsor the Astellas Future Innovator Prize in partnership with prominent laboratory incubator spaces that are designed as launchpads for high-potential biotech startups.
Winners will receive one year’s free space for an individual bench at the state-of-the-art lab facilities, along with all resident benefits. They will also gain access to Astellas’ R&D capabilities, business leaders, mentors and global network of partner academic institutes and biotechnology companies.
Entrepreneurial scientists, emerging life science companies and biotechnology startups that are developing pioneering scientific research or building novel therapeutic programs, modalities or programs.
Astellas is interested in most all areas where scientific innovation is flourishing to create new medicines. This includes new drug discovery biologies, novel drug modalities and unique technology platforms across oncology, immunology/allergy, neuromuscular disorders, sensory disorders and neuroscience. Fields of particular focus include regenerative medicine, genetic regulation, mitochondrial biology and immuno-oncology. Our interests span a range of drug modalities including cell therapy, gene therapy, vaccines, small molecules, antibodies and targeted drug delivery systems.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For more information, please visit our website at https://www.astellas.com/en
